<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The expression of CD10 in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells has been reported to correlate with <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>However, fibroblasts and immune cells positive for CD10 at the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> invasion front have not been comprehensively studied </plain></SENT>
<SENT sid="2" pm="."><plain>We classified CD10 expression patterns into three types of cells, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells (tCD10), stromal myofibroblasts (sCD10), and immune cells (iCD10), and investigated their correlation with the expression of transforming growth factor-β (TGF-β1) protein and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> budding grade </plain></SENT>
<SENT sid="3" pm="."><plain>Several cell surface markers were stained to detect the phenotype of iCD10(+) cells, including CD3, CD20, CD11b, CD14, CD15, and CD163 </plain></SENT>
<SENT sid="4" pm="."><plain>Specimens and follow-up data of 206 CRC patients were examined </plain></SENT>
<SENT sid="5" pm="."><plain>In multivariate analysis, iCD10 could be an independent prognostic factor for both recurrence-free survival and overall survival in stage I-III <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> (hazard ratio, 2.522 [1.299-4.896], P = 0.006; 2.890 [1.357-6.157], P = 0.006, respectively) </plain></SENT>
<SENT sid="6" pm="."><plain>The expression of sCD10 and iCD10 was strongly correlated with TGF-β1 expression in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> budding grade </plain></SENT>
<SENT sid="7" pm="."><plain>The phenotype of iCD10(+) cells was CD11b(+) and CD15(+) granulocytes </plain></SENT>
<SENT sid="8" pm="."><plain>The infiltration of sCD10(+) fibroblasts and iCD10(+) granulocytes at the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> invasion front might interact with TGF-β1 protein expression and enhance <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> budding grade </plain></SENT>
<SENT sid="9" pm="."><plain>The expression level of iCD10 at the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> invasion front represented an independent prognostic biomarker in stage I-III <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> and could be integrated into a new staging system </plain></SENT>
</text></document>